Fairview Pharmacy Services adopts Mscripts mobile health platform
MINNEAPOLIS — A pharmacy chain based in Minnesota is offering a new mobile app and web portal for its retail customers under a partnership with San Francisco-based Mscripts, the chain said Tuesday.
Fairview Pharmacy Services, which runs about 30 retail pharmacies across the state and also specialty, compounding and mail-order facilities, said the new app would allow customers to scan and refill prescriptions, receive pickup and dosage reminders and locate stores and specials. Non-smartphone users will have a text-messaging option.
"Fairview Pharmacy prides itself on our neighborhood focus and medical expertise," Fairview chief information officer Marlaine Villas said. "We are committed to delivering the finest, most innovative health solutions to our customers. Our mobile pharmacy solution furthers this mission, while affording our customers the ease and convenience of using their mobile phones to manage their prescription needs and access other services across our pharmacy — whether they be in the neighborhood or across the country."
The mobile app will operate on a secure network and is integrated with McKesson’s EnterpriseRx pharmacy-management system, allowing Fairview to offer a variety of mobile communication pathways. The app will be available starting later this year, free of charge, for iPhone and Android users.
"Fairview Pharmacy is strengthening its ties to the community by expanding the mobile adherence services it provides to its patients," Mscripts CEO Mark Cullen said. "The mobile phone has become a trusted, integral part of daily lives, and Fairview is making it easier for customers to refill prescriptions and manage their health information wherever they may be."
Famy Care wins approval for generic contraceptive
SILVER SPRING, Md. — The Food and Drug Administration has approved a generic contraceptive drug made by Famy Care, agency records show.
The agency approved Famy’s levonorgestrel and ethinyl estradiol tablets in the 0.02-mg/0.1-mg strengths.
The drug is a generic version of Aviane-28, made by Teva Women’s Health, a division of Israeli drug maker Teva Pharmaceutical Industries that previously went under the name Duramed.
FDA approves generic drug for bacterial vaginosis, protozoan infections
SILVER SPRING, Md. — The Food and Drug Administration has approved a new generic drug for treating bacterial and protozoan infections, according to the agency.
The FDA approved a generic version of Mission Pharmacal’s Tindamax (tinidazole) made by Unique Pharmaceuticals. The drug is a tablet in the 250-mg and 500-mg strengths.
Tindamax is used to treat bacterial vaginosis, trichomoniasis and giardiasis. The drug has annual sales of about $16.2 million, according to IMS Health.